• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死的治疗策略:抗心律失常治疗

[Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].

作者信息

Le Heuzey J Y, Copie X, Iliou M C, Guize L

机构信息

Service de cardiologie A, hôpital Broussais, Paris.

出版信息

Arch Mal Coeur Vaiss. 1998 Apr;91 Spec No 2:39-42.

PMID:9749275
Abstract

Antiarrhythmic therapy is a special case in the therapeutic strategy of acute myocardial infarction. There are very few controlled therapeutic trials and its use is mainly based on clinical experience rather than on scientific evidence. The most common arrhythmias requiring treatment in acute myocardial infarction are atrial fibrillation, ventricular tachycardia and ventricular fibrillation. There is no evidence to support the use Class I antiarrhythmics. Lidocain may be used in some cases. Similarly, contradictory results have been reported with the use of magnesium salts and the general tendency is not to use this ion in acute myocardial infarction. The most commonly used antiarrhythmic agents are the betablockers and amiodarone. The general principles of treatment should be respected: all antiarrhythmic drugs have negative inotropic effects, apart from digitalis. All antiarrhythmics may have a proarrhythmic effect including digitalis, especially in this clinical context. Whenever possible, continuous intravenous infusions are to be preferred to bolus injections. In addition, and when possible, electrotherapy is preferable to antiarrhythmic drug therapy. Finally, a number of cardiac arrhythmias observed in acute myocardial infarction should be "respected" or treated by electrotherapy but never by antiarrhythmic drugs.

摘要

抗心律失常治疗是急性心肌梗死治疗策略中的一个特殊情况。对照治疗试验非常少,其应用主要基于临床经验而非科学证据。急性心肌梗死中需要治疗的最常见心律失常是心房颤动、室性心动过速和心室颤动。没有证据支持使用Ⅰ类抗心律失常药物。在某些情况下可使用利多卡因。同样,关于镁盐的使用也有相互矛盾的报道,一般倾向于在急性心肌梗死中不使用这种离子。最常用的抗心律失常药物是β受体阻滞剂和胺碘酮。应遵循治疗的一般原则:除洋地黄外,所有抗心律失常药物都有负性肌力作用。所有抗心律失常药物都可能有致心律失常作用,包括洋地黄,尤其是在这种临床情况下。只要有可能,持续静脉输注优于大剂量注射。此外,在可能的情况下,电疗法优于抗心律失常药物治疗。最后,急性心肌梗死中观察到的一些心律失常应予以“观察”或用电疗法治疗,但绝不用抗心律失常药物治疗。

相似文献

1
[Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].急性心肌梗死的治疗策略:抗心律失常治疗
Arch Mal Coeur Vaiss. 1998 Apr;91 Spec No 2:39-42.
2
[Role of antiarrhythmics in the post-infarction period].
Arch Mal Coeur Vaiss. 2000 Apr;93(3 Spec No):65-9.
3
[Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].[抗心律失常药物在CAST试验后时代室性心律失常治疗中的应用]
Schweiz Med Wochenschr. 1994 Sep 3;124(35):1545-9.
4
[Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].[急性心肌梗死中心脏性猝死的预防性抗纤颤治疗]
Z Kardiol. 1988;77 Suppl 4:11-22.
5
Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).过去十年心肌梗死后患者的抗心律失常药物处方。意大利心肌梗死存活研究组(GISSI)的经验。
Arch Intern Med. 1995 May 22;155(10):1041-5.
6
[Antiarrhythmic drugs in atrial fibrillation].[心房颤动中的抗心律失常药物]
Rev Prat. 2002 Jun 15;52(12):1317-23.
7
Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats.胺碘酮与决奈达隆在大鼠急性心肌梗死期间的抗心律失常疗效比较
Eur J Pharmacol. 2007 Jun 14;564(1-3):150-7. doi: 10.1016/j.ejphar.2007.02.052. Epub 2007 Mar 7.
8
Antiarrhythmic effects of growth hormone--in vivo evidence from small-animal models of acute myocardial infarction and invasive electrophysiology.生长激素的抗心律失常作用——来自急性心肌梗死小动物模型和侵入性电生理学的体内证据
J Electrocardiol. 2008 Mar-Apr;41(2):144-51. doi: 10.1016/j.jelectrocard.2007.09.002.
9
[Ventricular cardiac arrhythmias. New anti-arrhythmia agents].[室性心律失常。新型抗心律失常药物]
Z Kardiol. 1996;85 Suppl 6:91-6.
10
[Magnesium: current studies--critical evaluation--consequences].[镁:当前研究——批判性评估——影响]
Z Kardiol. 1996;85 Suppl 6:147-51.